Literature DB >> 19457417

Acute bloody diarrhea: a medical emergency for patients of all ages.

Lori R Holtz1, Marguerite A Neill, Phillip I Tarr.   

Abstract

Acute bloody diarrhea should be considered a medical emergency. Its causes are frequently serious or actionable or both and are usually identified. However, acute bloody diarrhea as a stand-alone clinical presentation has received little scholarly attention in the past several decades. Although the range of possible causes of acute bloody diarrhea is broad, infectious considerations are paramount and should always be prioritized in the evaluation of such patients. History, examination, and laboratory testing should be focused on minimizing time to diagnosis (and, by extension, to implementing appropriate therapy). Strategically chosen tests and imaging, avoidance of extraneous diagnostic pursuits, and provision of supportive care while awaiting diagnostic clarity are central to the adroit management of patients with acute bloody diarrhea. Diagnostic considerations differ somewhat between adults and children but have many elements in common, including the need for vigilance in detecting Escherichia coli O157:H7 infection. In this review, we discuss diagnostic approaches (emphasizing the importance of rapid, accurate, and thorough microbiologic investigation) and measures that can be taken to support patients while awaiting information that determines the cause of their disease. These topics are discussed in the context of the medical care that is available to children and adults with bloody diarrhea in most institutions in developed nations.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19457417     DOI: 10.1053/j.gastro.2009.02.059

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  23 in total

1.  Infectious diarrhea: when to test and when to treat.

Authors:  Todd F Hatchette; Dana Farina
Journal:  CMAJ       Date:  2010-12-20       Impact factor: 8.262

2.  Antibiotic-Mediated Modulations of Outer Membrane Vesicles in Enterohemorrhagic Escherichia coli O104:H4 and O157:H7.

Authors:  Andreas Bauwens; Lisa Kunsmann; Helge Karch; Alexander Mellmann; Martina Bielaszewska
Journal:  Antimicrob Agents Chemother       Date:  2017-08-24       Impact factor: 5.191

Review 3.  Shiga toxin-producing Escherichia coli O104:H4: an emerging pathogen with enhanced virulence.

Authors:  Dakshina M Jandhyala; Vijay Vanguri; Erik J Boll; Yushuan Lai; Beth A McCormick; John M Leong
Journal:  Infect Dis Clin North Am       Date:  2013-07-24       Impact factor: 5.982

4.  Hemoconcentration: a major risk factor for neurological involvement in hemolytic uremic syndrome.

Authors:  Gianluigi Ardissino; Valeria Daccò; Sara Testa; Cristina Felice Civitillo; Francesca Tel; Ilaria Possenti; Mirco Belingheri; Pierangela Castorina; Nicolò Bolsa-Ghiringhelli; Silvana Tedeschi; Fabio Paglialonga; Stefania Salardi; Dario Consonni; Elena Zoia; Patrizia Salice; Giovanna Chidini
Journal:  Pediatr Nephrol       Date:  2014-08-23       Impact factor: 3.714

5.  Risk factors for the hemolytic uremic syndrome in children infected with Escherichia coli O157:H7: a multivariable analysis.

Authors:  Craig S Wong; Jody C Mooney; John R Brandt; Amy O Staples; Srdjan Jelacic; Daniel R Boster; Sandra L Watkins; Phillip I Tarr
Journal:  Clin Infect Dis       Date:  2012-03-19       Impact factor: 9.079

6.  Effects of antibiotics on Shiga toxin 2 production and bacteriophage induction by epidemic Escherichia coli O104:H4 strain.

Authors:  Martina Bielaszewska; Evgeny A Idelevich; Wenlan Zhang; Andreas Bauwens; Frieder Schaumburg; Alexander Mellmann; Georg Peters; Helge Karch
Journal:  Antimicrob Agents Chemother       Date:  2012-03-05       Impact factor: 5.191

7.  Real-Time PCR Assay for Detection and Differentiation of Shiga Toxin-Producing Escherichia coli from Clinical Samples.

Authors:  Xuan Qin; Eileen J Klein; Emmanouil Galanakis; Anita A Thomas; Jennifer R Stapp; Shannon Rich; Anne Marie Buccat; Phillip I Tarr
Journal:  J Clin Microbiol       Date:  2015-04-29       Impact factor: 5.948

8.  Case definitions of hemolytic uremic syndrome following Escherichia coli O157:H7 infection vary in validity.

Authors:  Gillian A M Tarr; Hanna N Oltean; Amanda I Phipps; Peter Rabinowitz; Phillip I Tarr
Journal:  Int J Med Microbiol       Date:  2018-10-10       Impact factor: 3.473

Review 9.  Recent advances in understanding enteric pathogenic Escherichia coli.

Authors:  Matthew A Croxen; Robyn J Law; Roland Scholz; Kristie M Keeney; Marta Wlodarska; B Brett Finlay
Journal:  Clin Microbiol Rev       Date:  2013-10       Impact factor: 26.132

10.  Strength of the association between antibiotic use and hemolytic uremic syndrome following Escherichia coli O157:H7 infection varies with case definition.

Authors:  Gillian A M Tarr; Hanna N Oltean; Amanda I Phipps; Peter Rabinowitz; Phillip I Tarr
Journal:  Int J Med Microbiol       Date:  2018-06-26       Impact factor: 3.473

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.